DD
Du Pont De Nemours E I
Delisted
DD was delisted on the 31st of August, 2017.
Financial journalist opinion
Neutral
PRNewsWire
15 hours ago
DuPont Powers AI and Next-Gen Electronics with Advanced Interconnect Innovations at JPCA Show 2025
TOKYO , June 3, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced its participation in the Total Solution Exhibition for Electronic Equipment 2025 (JPCA Show 2025), taking place from June 4-6 at the Tokyo Big Sight East Exhibition Halls. At Booth #6C-03, DuPont will showcase its extensive portfolio of advanced interconnect solutions, which encompass fine line, signal integrity, power and thermal management.
Negative
Zacks Investment Research
5 days ago
Here's Why You Should Hold DuPont Stock in Your Portfolio for Now
Innovation, cost savings and healthcare acquisitions support DD as it navigates weak demand and hefty separation costs in 2025.
Neutral
Zacks Investment Research
6 days ago
DOW vs. DD: Which Chemical Giant Deserves a Spot in Your Portfolio?
Dow tackles weak demand with cost cuts and cash actions, while DuPont gains from acquisitions in healthcare and innovation.
Neutral
Zacks Investment Research
1 week ago
DuPont Achieves 100% Renewable Electricity in EU Operations
DD hits 100% renewable electricity for EU operations, marking a major step toward its 2050 net-zero emissions goal using RECs and solar installations.
Neutral
PRNewsWire
1 week ago
DuPont Achieves 100 Percent Renewable Electricity Across its European Union Operations
Company marks significant progress towards 2050 climate goals WILMINGTON, Del. , May 27, 2025 /PRNewswire/ -- DuPont (NYSE: DD) today announced 100 percent of its grid electricity is from renewable sources across its entire European Union (EU) operations, through the use of Renewable Energy Certificates (RECs).
Positive
Zacks Investment Research
1 week ago
DuPont Launches AmberChrom TQ1 Resin for Biopharma Applications
DD launches AmberChrom TQ1 resin, boosting oligonucleotide and peptide purification with high capacity, purity, and scalability.
Neutral
PRNewsWire
1 week ago
DuPont Expands Bioprocessing Portfolio with Launch of DuPont™ AmberChrom™ TQ1 Chromatography Resin
Agarose-based chromatography resin supports purification of oligonucleotides and peptides for biopharma applications WILMINGTON, Del. , May 22, 2025 /PRNewswire/ -- DuPont has expanded its bioprocessing portfolio with the launch of DuPont™ AmberChrom™ TQ1 chromatography resin for the purification of oligonucleotides and peptides in support of a wide-range of biopharma applications.
Positive
Seeking Alpha
2 weeks ago
Pessimism Overdone? 2 Recession-Resistant Dividend Stocks To Reward Long-Term Investors
The market has recovered most of its losses from last month's correction, and many quality stocks appear expensive again, prompting some investors to wait for another correction. DuPont de Nemours, Inc. offers 27% upside potential, a safe 2%+ yield, and strong fundamentals, with growth expected as macro conditions improve and a segment spin-off ahead. PepsiCo, Inc. faces near-term headwinds and slow growth, but its 4% yield, robust balance sheet, and transition to healthier products offer long-term upside.
Neutral
PRNewsWire
2 weeks ago
DuPont and Epicore Biosystems Collaborate to Advance Worker Safety Through Smart Wearable Technology
CAMBRIDGE, Mass. and WILMINGTON, Del.
Neutral
GlobeNewsWire
2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DuPont de Nemours, Inc. - DD
NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DuPont de Nemours, Inc. (“DuPont” or the “Company”) (NYSE: DD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Charts implemented using Lightweight Charts™